Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Geriatr Oncol. 2015 Feb 7;6(2):133–140. doi: 10.1016/j.jgo.2014.12.002

Table 1.

Patient characteristics comparison between the palliative intent group and curative intent group (N = 500).

Variable Curative intent group (n = 179) a Palliative intent group (n = 321)b p-Value
Age, years
 Mean (range) 73.0 (65–89) 73.2 (65–91) 0.82
 SD 6.1 6.3
No. (%) No. (%)
Race
 White 144 (80.4) 282 (87.9) 0.05
 Black 23 (12.9) 19 (5.9)
 Asian 9 (5.0) 17 (5.3)
 Other 3 (1.7) 3 (0.9)
Gender
 Male 64 (35.8) 155 (48.3) 0.007
 Female 115 (64.2) 166 (51.7)
BMI
 <25 88 (49) 165 (51.7) 0.58
 ≥25 91 (51) 154 (48.3)
 Missing 2
Cancer type
 Breast 39 (21.8) 18 (5.6) <0.001
 Lung 31 (17.3) 112 (34.9)
 GI 54 (30.2) 81 (25.2)
 GYN 38 (21.2) 49 (15.3)
 GU 11 (6.2) 39 (12.2)
 Other 6 (3.3) 22 (6.8)
Education
 Less than high school 6 (3.4) 12 (3.8) 0.86
 High school graduate 60 (33.5) 115 (35.9)
 Associate/bachelor’s degree 77 (43.0) 125 (39.0)
 Advanced degree Missing 36 (20.1) 68 (21.3)
Marital status
 Married 109 (60.9) 197 (61.4) 0.70
 Widowed 43 (24.0) 70 (21.8)
 Single 7 (3.9) 9 (2.8)
 Separated, divorced 20 (11.2) 45 (14.0)
Employment status
 Full or part time 25 (14.0) 58 (18.1) 0.46
 Retired, homemaker, unemployed 147 (82.1) 248 (77.5)
 Disabled, medical leave 7 (3.9) 14 (4.4)
 Missing 1
Standard dose
 Yes 153 (85.5) 240 (74.8) 0.005
 No 26 (14.5) 81 (25.2)
First line of chemotherapy
 Yes 165 (92.2) 190 (59.2) <0.001
 No 14 (7.8) 131 (40.8)
No. of chemotherapy drugs
 Mono-chemotherapy 28 (15.6) 121 (37.7) <0.001
 Poly-chemotherapy 151 (84.4) 200 (62.3)
Duration, days
 Mean (range) 92.8 (1–491) 94.0 (1–598) 0.854
 SD 65.0 81.0

Abbreviations: SD, standard deviation; BMI, body mass index; GI, gastrointestinal; GYN, gynecologic; GU, genitourinary.

a

Includes stages I–III disease, except IIIb lung cancer

b

Includes stage IV disease and stage IIIb lung cancer.